Deffai
1 known investors
Deffai is an AI-native regulatory affairs platform that helps life sciences companies prepare and strengthen FDA submissions using domain-specific AI built on review patterns and guidances. It targets biotech and medical device firms working on areas such as cell and gene therapy, vaccines, oncology, and combination products, and is staffed by former FDA reviewers and decision-makers.